Yuhan Corporation: Hypertension trials

The registry lists 23 Hypertension studies with Yuhan Corporation as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 2Phase 3 9Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231CNot yet recruitingNCT07590167Phase 1
• Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322Not yet recruitingNCT07312799Phase 1
• A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231CNot yet recruitingNCT07312773Phase 1
• A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227BRecruitingNCT06441630Phase 3
• Phase III Study to Evaluate the Efficacy and Safety of AD-209RecruitingNCT06348576Phase 3
• Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022CompletedNCT06448962Phase 3
• Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and HypercholesterolemiaCompletedNCT06293261
• Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential HypertensionActive, not recruitingNCT06282549
• A Study to Evaluate the Efficacy and Safety of AD-209CompletedNCT05631990Phase 2
• Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102CompletedNCT04600284Phase 1
• Determining the Optimal Dose of AD-209 in Patients With Essential HypertensionCompletedNCT04218552Phase 2
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineCompletedNCT04158076Phase 3
• Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With DyslipidemiaCompletedNCT03951207Phase 4
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and TelmisartanCompletedNCT03872232Phase 3
• Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy VolunteersCompletedNCT03662620Phase 1
• High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and HypertensionCompletedNCT03474562Phase 4
• Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With HypertensionCompletedNCT03267329Phase 4
• Clinical Trial to Evaluate the Efficacy and Safety of YHP1701CompletedNCT03103256Phase 3
• Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and HyperlipidemiaCompletedNCT03067688Phase 3
• Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine TreatmentCompletedNCT02620163Phase 3
• PK Study of YH22162 FDC Compared to Combination of Twynsta and HygrotonCompletedNCT02496910Phase 1
• Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)CompletedNCT02152969Phase 1
• Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and HyperlipidemiaCompletedNCT01914432Phase 3